Search results
Filter
Filetype
Your search for "Longqi Liu 2025 single cell spatial omics keynote speaker conference" yielded 14832 hits
Cacci et al exp cell res 2007
doi:10.1016/j.yexcr.2006.11.001 Research Article Generation of human cortical neurons from a new immortal fetal neural stem cell line E. Caccia,1, A. Villab,2, M. Parmarc, M. Cavallaroa, N. Mandahld, O. Lindvalle, A. Martinez-Serranob, Z. Kokaiaa,⁎ aLaboratory of Neural Stem Cell Biology, Section of Restorative Neurology, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, BMC B
Information for presenting speakers
Important information for speakers in parallel sessionsBe sure when you are scheduled to make presentation.Each presentation room will be equipped with a standard overhead projector, a screen and a personal computer for power point presentationsPlease remember that you are expected to arrive 15 minutes before your session starts where your presentation is scheduled, in order to make last arrangeme
https://www.ses.lu.se/en/qmod/information-presenting-speakers - 2026-07-11
No title
Liquid biopsy allows assessment of multiple analytes, providing temporal information with potential for improving understanding of cancer evolution and clinical management of patients. Although liquid biopsies are intensely investigated for prediction and response monitoring, preanalytic variables are of primary concern for clinical implementation, including categories of collection method and sam
No title
Afghanistan Programme Conferences 2024-2025 - The Raoul Wallenberg Institute of Human Rights and Hum
No title
High-throughput sequencing of adaptive immune receptor repertoires (AIRR, i.e., IG and TR) has revolutionized the ability to carry out large-scale experiments to study the adaptive immune response. Since the method was first introduced in 2009, AIRR sequencing (AIRR-Seq) has been applied to survey the immune state of individuals, identify antigen-specific or immune-state-associated signatures of i
No title
Cell culture techniques are strongly connected with modern scientific laboratories and production facilities. Thus, choosing the most suitable medium for the cells involved is vital, not only directly to optimise cell viability but also indirectly to maximise the reliability of the experiments performed with the cells. Fetal bovine or calf serum (FBS or FCS, respectively) is the most commonly used
No title
Fifth-generation (5G) new radio (NR) deployments are being rolled out in both the C–band (3.3 - 5.0 GHz) and millimeter-wave (mmWave) band (24.5 - 29.5 GHz). For outdoor scenarios, the C–band is expected to provide wide area coverage and throughput uniformity, whereas the mmWave band is expected to provide ultra-high throughput to dedicated areas within the C-band coverage. Due to the differences
No title
The effects of genetic variation on molecular functions predisposing to type 2 diabetes are still largely unknown. Here, in a specifically designed diabetes model, we couple separate gene loci to mechanisms of P-cell pathology. Niddm1i is a major glucose-controlling 16-Mb region in the diabetic GK rat that causes defective insulin secretion and corresponds to loci in humans and mice associated wit
No title
Isolation and characterization of circulating tumor cells (CTCs) present a noninvasive alternative to monitor disease progression in individual patients. However, the heterogeneous lineage specificity of CTCs makes it difficult to isolate and identify possible CTCs by a liquid biopsy. Better label-free methods for the isolation of viable CTCs are needed. Our solution is a combined approach that is
No title
ZnO nanorods (NRs) with high surface area to volume ratio and biocompatibility is used as an efficient photosensitizer carrier system and at the same time providing intrinsic white light needed to achieve cancer cell necrosis. In this letter, ZnO nanorods used for the treatment of breast cancer cell (T47D) are presented. To adjust the sample for intracellular experiments, we have grown the ZnO nan
FACS Instruments
Learn more about the cell sorters and analysers available at the FACS Core Facility Sorters: BD FACS Aria III The BD FACS Aria III has 5 laser lines: near UV at 375nm, violet at 405nm, blue at 488nm, yellow-green at 561 nm and red at 635nm. The violet and near UV are co-linear and cannot be used simultaneously. It can detect up to 16 colours and two scatter parameters. BD FACS ARIA III Documents
https://www.stemcellcenter.lu.se/core-facilities/facs-facility/facs-instruments - 2026-07-11
No title
Background: Human fibroblasts can be directly converted to several subtypes of neurons, but cortical projection neurons have not been generated. Methods: Here we screened for transcription factor combinations that could potentially convert human fibroblasts to functional excitatory cortical neurons. The induced cortical (iCtx) cells were analyzed for cortical neuronal identity using immunocytochem
No title
2022-08-19Post Doc Scholarship In Bioinformatics
Brevmall Facul ty o f Medic ine Department o f Labora tory Medic ine, Lund Announcement: Post doc scholarship in bioinformatics Scholarship A postdoc scholarship is available for a highly motivated candidate with a background in bioinformatics and with interest in cancer research. The Molecular Pediatric Oncology lab, led by PI Daniel Bexell, is working with childhood cancer neuroblastoma. The ove
https://www.tcr.lu.se/sites/tcr.lu.se/files/2022-08/2022-08-19Post%20doc%20scholarship%20in%20bioinformatics.pdf - 2026-07-12
No title
Next generation immuno-oncological targets for cancer therapy
Immuno-oncological (I-O) treatment methods have revolutionized cancer therapy and tremendous clinical benefits are achieved in some cancer patients. However, today a limited number of I-O drug targets are used and only a fraction of all cancer patients has a therapeutic response. We need to further understand the immune system in cancer in order to develop novel treatment strategies and improve su
No title
No title
Acute myeloid leukemia (AML) is a highly heterogeneous disease caused by sequential accumulation of mutations in the genome of hematopoietic stem cells (HSCs) or myeloid precursors, giving rise to formation of leukemia stem cells (LSC). More than 200 recurrent mutations have been described, although each patient will carry a small subset of these. The mutations are used as a basis for classificati
